{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2025-P-1807\" sorted by posted_date descending", "rows": [["FDA-2025-P-1807-0369", "FDA", "FDA-2025-P-1807", "Amendment and Supplement from Interest of Justice", "Other", "Amendment", "2026-09-30T04:00:00Z", 2026, 9, "2026-09-30T04:00:00Z", null, "2026-09-30T22:49:09Z", null, 0, 0, "09000064b95f0cdd"], ["FDA-2025-P-1807-0368", "FDA", "FDA-2025-P-1807", "Response Letter", "Other", "Response(s)", "2026-09-15T04:00:00Z", 2026, 9, "2026-09-15T04:00:00Z", null, "2026-09-15T19:11:17Z", null, 0, 0, "09000064b955ee1b"], ["FDA-2025-P-1807-0365", "FDA", "FDA-2025-P-1807", "Interim Response to Interest of Justice", "Other", "Response(s)", "2025-12-12T05:00:00Z", 2025, 12, "2025-12-12T05:00:00Z", null, "2025-12-12T21:12:16Z", null, 0, 0, "09000064b90c915d"], ["FDA-2025-P-1807-0033", "FDA", "FDA-2025-P-1807", "21a - Executive Order 13139 Wikisource the free online library", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:35:11Z", null, 0, 0, "09000064b8e1f1d8"], ["FDA-2025-P-1807-0038", "FDA", "FDA-2025-P-1807", "24 - National Security Presidential Memorandum NSPM 2 The White House", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:36:22Z", null, 0, 0, "09000064b8e1f1fc"], ["FDA-2025-P-1807-0040", "FDA", "FDA-2025-P-1807", "25 - STATUTE 67 Pg. 631", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:36:41Z", null, 0, 0, "09000064b8e1f201"], ["FDA-2025-P-1807-0020", "FDA", "FDA-2025-P-1807", "12a - U.S. Department of Defense _ Contract", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:28:11Z", null, 0, 0, "09000064b8e1d4a3"], ["FDA-2025-P-1807-0009", "FDA", "FDA-2025-P-1807", "3 -  Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derive", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:25:58Z", null, 0, 0, "09000064b8e1dd5b"], ["FDA-2025-P-1807-0015", "FDA", "FDA-2025-P-1807", "8-  Moderna Inc 2018 form S1 registration statement US securities and Exchange Commission_compressed", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:27:09Z", null, 0, 0, "09000064b8e3d122"], ["FDA-2025-P-1807-0025", "FDA", "FDA-2025-P-1807", "15a - GAO-21-387 highlights", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:33:00Z", null, 0, 0, "09000064b8e1f1c8"], ["FDA-2025-P-1807-0027", "FDA", "FDA-2025-P-1807", "16a - GAO 21 108 Highlights DEFENSE PRODUCTION ACT Opportunities Exist to Increase Transparency and Identify Future Actions", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:33:31Z", null, 0, 0, "09000064b8e1f1cc"], ["FDA-2025-P-1807-0034", "FDA", "FDA-2025-P-1807", "22 - Executive Order 13989 Ethics Commitments by Executive Branch Personnel The American Presidency Project", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:35:34Z", null, 0, 0, "09000064b8e1f1f0"], ["FDA-2025-P-1807-0011", "FDA", "FDA-2025-P-1807", "5 - Journal of Molecular Biology _ ScienceDirect_com by Elsevier", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:26:20Z", null, 0, 0, "09000064b8e1d49d"], ["FDA-2025-P-1807-0019", "FDA", "FDA-2025-P-1807", "12 - Pfizer-Inc.-Covid-19-Vaccine-Contract", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:28:01Z", null, 0, 0, "09000064b8e1d4a2"], ["FDA-2025-P-1807-0016", "FDA", "FDA-2025-P-1807", "9 -  ii Moderna Inc 2019 Form 10K annual Report US Securities and Exchange Commission_compressed", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:27:25Z", null, 0, 0, "09000064b8e3d219"], ["FDA-2025-P-1807-0017", "FDA", "FDA-2025-P-1807", "10  - iii NioNtech SE 2019 Form F1 Registration Statement US Securities And Exchange Commission_compressed", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:27:39Z", null, 0, 0, "09000064b8e3d21e"], ["FDA-2025-P-1807-0012", "FDA", "FDA-2025-P-1807", "6 - Nature Biotechnology", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:26:31Z", null, 0, 0, "09000064b8e1d49e"], ["FDA-2025-P-1807-0018", "FDA", "FDA-2025-P-1807", "11 - Opening Ceremony World Health Summit 2021 Speech Stefan Oelrich", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:27:52Z", null, 0, 0, "09000064b8e1d4a1"], ["FDA-2025-P-1807-0021", "FDA", "FDA-2025-P-1807", "13 -  Award Contract No W911QY20C0100 by and between Moderna US Moderna Inc. - Business Contracts Justia", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:28:21Z", null, 0, 0, "09000064b8e1f1c4"], ["FDA-2025-P-1807-0024", "FDA", "FDA-2025-P-1807", "15 - GAO-21-387_compressed", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:29:00Z", null, 0, 0, "09000064b8e1f1c7"], ["FDA-2025-P-1807-0030", "FDA", "FDA-2025-P-1807", "19 -  Advanced Biological Research Group to Study Effects of mRNA on Women's Reproduction _ Morningstar", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:34:35Z", null, 0, 0, "09000064b8e1f1d5"], ["FDA-2025-P-1807-0031", "FDA", "FDA-2025-P-1807", "20 - Whistleblower Doctor Drops Bombshell on mRNA COVID19 Vaccines But Whats the Evidence", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:34:46Z", null, 0, 0, "09000064b8e1f1d6"], ["FDA-2025-P-1807-0032", "FDA", "FDA-2025-P-1807", "21 - 64 FR 54175 Improving Health Protection of Military Personnel Participating in Particular Military Operations Content Details", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:34:56Z", null, 0, 0, "09000064b8e1f1d7"], ["FDA-2025-P-1807-0036", "FDA", "FDA-2025-P-1807", "23 - Executive Order 14102 Ordering the Selected Reserve and Certain Members of the Individual Ready Reserve of the Armed Forces to", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:35:57Z", null, 0, 0, "09000064b8e1f1f6"], ["FDA-2025-P-1807-0004", "FDA", "FDA-2025-P-1807", "1 - Evidence of admin remedy absolved IOJ Cit Pet 2023 FDA_compressed", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T22:37:42Z", null, 0, 0, "09000064b8e1dd56"], ["FDA-2025-P-1807-0005", "FDA", "FDA-2025-P-1807", "WHO Ethics Complaints Sept 18 2024 To MDS EUL Referred to National Authority", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:24:46Z", null, 0, 0, "09000064b8e1dd57"], ["FDA-2025-P-1807-0006", "FDA", "FDA-2025-P-1807", "1 - Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:25:00Z", null, 0, 0, "09000064b8e1dd58"], ["FDA-2025-P-1807-0008", "FDA", "FDA-2025-P-1807", "2025-05-21-Chairman-Ron-Johnson-Opening-Statement-FINAL", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:25:44Z", null, 0, 0, "09000064b8e1dd5a"], ["FDA-2025-P-1807-0022", "FDA", "FDA-2025-P-1807", "13a - U.S. Department of Defense _ Contract", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:28:35Z", null, 0, 0, "09000064b8e1f1c5"], ["FDA-2025-P-1807-0029", "FDA", "FDA-2025-P-1807", "18 -  2021-04-08_Clyburn to Hatfill re PPE", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:34:23Z", null, 0, 0, "09000064b8e1f1d4"], ["FDA-2025-P-1807-0037", "FDA", "FDA-2025-P-1807", "23a - Federal Register Ordering the Selected Reserve and Certain Members of the Individual Ready Reserve of the Armed Forces to Acti", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:36:10Z", null, 0, 0, "09000064b8e1f1fb"], ["FDA-2025-P-1807-0003", "FDA", "FDA-2025-P-1807", "1 - Department of Defense - FOIA Requests from IOJ", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T22:06:35Z", null, 0, 0, "09000064b8e1dd55"], ["FDA-2025-P-1807-0001", "FDA", "FDA-2025-P-1807", "Acknowledgment Letter from FDA DMB to Interest of Justice", "Other", "Acknowledgement Letter/Receipt", "2025-06-27T04:00:00Z", 2025, 6, "2025-06-27T04:00:00Z", null, "2025-06-27T22:04:17Z", null, 0, 0, "09000064b8e1ef83"], ["FDA-2025-P-1807-0002", "FDA", "FDA-2025-P-1807", "Petition for Reclassification from Interest of Justice", "Other", "Petition(s)", "2025-06-27T04:00:00Z", 2025, 6, "2025-06-27T04:00:00Z", null, "2025-12-18T10:00:13Z", null, 1, 0, "09000064b8e1ef7d"], ["FDA-2025-P-1807-0010", "FDA", "FDA-2025-P-1807", "4 - Current Issues in Molecular Biology _ An Open Access Journal from MDPI", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:26:07Z", null, 0, 0, "09000064b8e1d49c"], ["FDA-2025-P-1807-0013", "FDA", "FDA-2025-P-1807", "7 - Genome-wide host-pathogen analyses reveal genetic interaction points in tuberculosis disease _ Nature Communications", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:26:44Z", null, 0, 0, "09000064b8e1d49f"], ["FDA-2025-P-1807-0007", "FDA", "FDA-2025-P-1807", "2 - Immune imprinting breadth of variant recognition and germinal center response in human SARS CoV2 infection and vaccination Cell", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:25:15Z", null, 0, 0, "09000064b8e1dd59"], ["FDA-2025-P-1807-0023", "FDA", "FDA-2025-P-1807", "14 - JAMS_7_Packard", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:28:49Z", null, 0, 0, "09000064b8e1f1c6"], ["FDA-2025-P-1807-0028", "FDA", "FDA-2025-P-1807", "17 - Steven Hatfill Dana parish They Lied", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:33:43Z", null, 0, 0, "09000064b8e1f1cf"], ["FDA-2025-P-1807-0039", "FDA", "FDA-2025-P-1807", "24a - National Security Memorandum (NSM) on Artificial Intelligence Democracy Tech Initiative Markup - DFRLab", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:36:31Z", null, 0, 0, "09000064b8e1f1fd"], ["FDA-2025-P-1807-0041", "FDA", "FDA-2025-P-1807", "26 - RFK Jr. seeks to remove COVID-19 vaccine recommendation for children", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:36:50Z", null, 0, 0, "09000064b8e1f202"], ["FDA-2025-P-1807-0014", "FDA", "FDA-2025-P-1807", "8 - Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine _ New England Journal of Medicine", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:26:58Z", null, 0, 0, "09000064b8e1d4a0"], ["FDA-2025-P-1807-0026", "FDA", "FDA-2025-P-1807", "16 - GAO 21 108 DEFENSE PRODUCTION ACT Opportunities Exist to Increase Transparency and Identify Future Actions to Mitigate Medical", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:33:14Z", null, 0, 0, "09000064b8e1f1ca"], ["FDA-2025-P-1807-0035", "FDA", "FDA-2025-P-1807", "22a - Federal Register Initial Rescissions of Harmful Executive Orders and Actions", "Supporting & Related Material", "Background Material", "2025-06-27T04:00:00Z", 2025, 6, null, null, "2025-06-27T19:35:44Z", null, 0, 0, "09000064b8e1f1f5"]], "truncated": false, "filtered_table_rows_count": 44, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2025-P-1807"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2025-P-1807", "results": [{"value": "FDA", "label": "FDA", "count": 44, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2025-P-1807&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2025-P-1807", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 39, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2025-P-1807&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 5, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2025-P-1807&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2025-P-1807", "results": [{"value": 2025, "label": 2025, "count": 42, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2025-P-1807&posted_year=2025", "selected": false}, {"value": 2026, "label": 2026, "count": 2, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2025-P-1807&posted_year=2026", "selected": false}], "truncated": false}}, "suggested_facets": [], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2.0165522582829, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}